ELNSF logo

Element Nutritional Sciences Inc. (ELNSF)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist Element Nutritional Sciences Inc. (ELNSF) ein Consumer Defensive-Unternehmen mit einer Bewertung von 0. Bewertet mit 49/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 18. März 2026
49/100 KI-Bewertung

Element Nutritional Sciences Inc. (ELNSF) Konsumgueeter-Geschaeftsueberblick

CEOVito Sanzone
HauptsitzBurlington, CA
IPO-Jahr2021

Element Nutritional Sciences Inc. is a nutraceutical company focused on developing and retailing specialized nutritional products like Rejuvenate and JAKTRX. Targeting the consumer defensive sector, the company addresses muscle mass loss and performance enhancement through both online and brick-and-mortar channels, operating primarily out of Canada.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 18. März 2026

Investmentthese

Element Nutritional Sciences Inc. presents a high-risk, high-reward investment opportunity within the nutraceutical sector. The company's focus on specialized products like Rejuvenate, targeting age-related muscle loss, aligns with the growing aging population demographic. However, the company's negative profit margin of -253.5% and gross margin of -27.1% raise concerns about its financial sustainability. Key catalysts include expanding distribution networks and successful product launches. The high beta of 3.09 indicates significant volatility, making it suitable for investors with a high-risk tolerance. The company's ability to improve its margins and achieve profitability will be critical for long-term success.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market Cap of $0.01B indicates a micro-cap company with potential for high growth but also significant risk.
  • P/E Ratio of -0.95 reflects the company's current lack of profitability.
  • Profit Margin of -253.5% highlights significant challenges in achieving profitability and managing expenses.
  • Gross Margin of -27.1% indicates that the cost of goods sold exceeds revenue, posing a serious concern for the company's financial health.
  • Beta of 3.09 suggests the stock is significantly more volatile than the market average, indicating higher risk.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Proprietary formulations like Rejuvenate.
  • Direct-to-consumer sales channel.
  • Focus on a growing market segment (aging population).
  • Established brand in the nutraceutical market.

Schwaechen

  • Negative profit margin.
  • High cost of goods sold.
  • Limited financial resources.
  • High beta indicating high volatility.

Katalysatoren

  • Upcoming: Expansion of distribution agreements with major retailers to increase product availability.
  • Ongoing: Continued marketing efforts to increase brand awareness and drive sales of Rejuvenate and JAKTRX.
  • Upcoming: Launch of new nutraceutical products targeting specific health needs.
  • Ongoing: Research and development efforts to improve existing formulations and create innovative products.

Risiken

  • Potential: Intense competition in the nutraceutical industry could erode market share.
  • Potential: Changing consumer preferences could impact demand for existing products.
  • Ongoing: Negative profit margin and gross margin raise concerns about financial sustainability.
  • Potential: Regulatory challenges and compliance costs could increase operating expenses.
  • Ongoing: Limited financial resources may hinder growth initiatives.

Wachstumschancen

  • Expansion of Distribution Channels: Element Nutritional Sciences can drive growth by expanding its distribution network through partnerships with major retailers and online platforms. Increasing the availability of Rejuvenate and JAKTRX products in key markets will enhance brand visibility and accessibility, potentially capturing a larger market share within the growing nutraceutical industry. This expansion could target both domestic and international markets, leveraging e-commerce to reach a broader customer base. Timeline: Ongoing.
  • New Product Development: Investing in research and development to create new, innovative nutraceutical products can drive future growth. Focusing on emerging health trends and unmet consumer needs will allow Element Nutritional Sciences to diversify its product portfolio and attract new customer segments. This includes exploring new formulations, delivery methods, and target health conditions. Timeline: Ongoing.
  • Strategic Partnerships: Forming strategic alliances with healthcare providers, fitness centers, and wellness programs can create new avenues for product promotion and sales. These partnerships can provide access to targeted customer groups and enhance the credibility of Element Nutritional Sciences' products. Collaborations with influencers and brand ambassadors in the health and fitness space can further amplify marketing efforts. Timeline: Ongoing.
  • Direct-to-Consumer (DTC) Sales Growth: Enhancing the company's online presence and DTC capabilities can improve customer engagement and drive sales. Investing in e-commerce infrastructure, digital marketing, and personalized customer experiences will strengthen the company's brand loyalty and create a more direct relationship with consumers. This includes optimizing the company's website, social media channels, and email marketing campaigns. Timeline: Ongoing.
  • International Market Expansion: Exploring opportunities to expand into international markets, particularly in regions with a growing interest in health and wellness, can significantly increase revenue. Tailoring product offerings and marketing strategies to meet the specific needs and preferences of different international markets will be crucial for success. This includes conducting market research, establishing local partnerships, and adapting product formulations to comply with local regulations. Timeline: Ongoing.

Chancen

  • Expansion of distribution channels.
  • New product development targeting emerging health trends.
  • Strategic partnerships with healthcare providers.
  • International market expansion.

Risiken

  • Intense competition in the nutraceutical industry.
  • Changing consumer preferences.
  • Regulatory challenges.
  • Economic downturn affecting consumer spending.

Wettbewerbsvorteile

  • Proprietary Formulations: Rejuvenate's unique formulation provides a competitive edge.
  • Direct-to-Consumer Channel: Online sales provide direct customer relationships and data.
  • Brand Recognition: Established brand in the nutraceutical market.

Ueber ELNSF

Element Nutritional Sciences Inc., formerly known as Element Nutrition Inc., was rebranded in June 2021 to reflect its focus on science-backed nutritional solutions. The company develops, manufactures, and retails a range of nutraceutical products designed to address specific health and wellness needs. Its flagship product, Rejuvenate, is a proprietary formulation aimed at combating the natural loss of muscle mass associated with aging and various medical conditions. This product is designed to assist in the rebuilding, restoration, and rejuvenation of muscle tissue. Additionally, Element Nutritional Sciences offers JAKTRX, a line of performance supplements targeted at athletes and active individuals seeking to enhance their physical performance. The company distributes its products through a combination of retail partnerships and direct-to-consumer online sales channels. This dual approach allows Element Nutritional Sciences to reach a broad customer base while maintaining control over its brand and customer experience. Headquartered in Burlington, Canada, Element Nutritional Sciences is committed to innovation and scientific rigor in the development of its nutritional products, striving to meet the evolving needs of health-conscious consumers. The company's focus on specialized formulations and direct engagement with customers positions it within the competitive landscape of the nutraceutical industry.

Was das Unternehmen tut

  • Develops proprietary nutraceutical formulations.
  • Manufactures nutritional products targeting muscle mass loss and performance enhancement.
  • Retails products through online channels.
  • Distributes products through retail stores.
  • Offers Rejuvenate for combating age-related muscle loss.
  • Provides JAKTRX performance supplements for athletes.

Geschaeftsmodell

  • Develops and patents proprietary nutraceutical formulations.
  • Manufactures and packages products for retail and online sales.
  • Generates revenue through direct-to-consumer online sales.
  • Partners with retailers to distribute products in stores.

Branchenkontext

Element Nutritional Sciences operates within the competitive packaged foods industry, specifically focusing on the nutraceutical segment. This sector is characterized by increasing consumer interest in health and wellness, driving demand for specialized nutritional products. The market is highly competitive, with established players and emerging brands vying for market share. Element Nutritional Sciences differentiates itself through its proprietary formulations like Rejuvenate, targeting specific health needs. The company's success depends on its ability to innovate, effectively market its products, and navigate the complex regulatory landscape of the nutraceutical industry.

Wichtige Kunden

  • Individuals experiencing age-related muscle loss.
  • Athletes and active individuals seeking performance enhancement.
  • Health-conscious consumers looking for nutritional supplements.
  • Retailers who stock and sell nutraceutical products.
KI-Zuversicht: 71% Aktualisiert: 18. März 2026

Finanzdaten

Chart & Info

Element Nutritional Sciences Inc. (ELNSF) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer ELNSF verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ELNSF.

Kursziele

Wall-Street-Kurszielanalyse fuer ELNSF.

MoonshotScore

49/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ELNSF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Vito Sanzone

Unknown

Information about Vito Sanzone's background is not available in the provided context. Further research would be needed to provide details on his career history, education, and previous roles.

Erfolgsbilanz: Information about Vito Sanzone's track record is not available in the provided context. Further research would be needed to provide details on key achievements, strategic decisions, and company milestones under his leadership.

ELNSF OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Element Nutritional Sciences Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited operating history, may be thinly traded, and are subject to less stringent regulatory oversight than companies listed on major exchanges like the NYSE or NASDAQ. This tier is also known as the 'Pink Sheets'.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: As an OTC Other stock, ELNSF likely experiences low trading volume and a wide bid-ask spread. This can make it difficult to buy or sell shares quickly and at a desired price. The limited liquidity increases the risk of significant price fluctuations and potential losses, particularly for large orders. Investors should exercise caution and be prepared for potential delays in executing trades.
OTC-Risikofaktoren:
  • Limited Liquidity: Low trading volume can make it difficult to buy or sell shares.
  • Lack of Transparency: Disclosure status is unknown, raising concerns about financial reporting.
  • Price Volatility: OTC stocks are often subject to significant price swings.
  • Regulatory Scrutiny: OTC stocks are subject to less regulatory oversight than exchange-listed stocks.
  • Going Concern Risk: Companies on the OTC Other tier may face challenges in maintaining operations.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Assess the company's management team and their experience.
  • Research the company's products and market position.
  • Evaluate the company's competitive landscape.
  • Check for any legal or regulatory issues.
  • Monitor trading volume and price fluctuations.
  • Consult with a financial advisor.
Legitimitaetssignale:
  • Company has a registered business address.
  • Products are available for sale online and in retail stores.
  • Company has a website and social media presence.
  • Company has been in operation for several years.
  • Company has patents on its formulations.

Haeufige Fragen zu ELNSF

What are the key factors to evaluate for ELNSF?

Element Nutritional Sciences Inc. (ELNSF) currently holds an AI score of 49/100, indicating low score. Key strength: Proprietary formulations like Rejuvenate.. Primary risk to monitor: Potential: Intense competition in the nutraceutical industry could erode market share.. This is not financial advice.

How frequently does ELNSF data refresh on this page?

ELNSF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ELNSF's recent stock price performance?

Recent price movement in Element Nutritional Sciences Inc. (ELNSF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary formulations like Rejuvenate.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ELNSF overvalued or undervalued right now?

Determining whether Element Nutritional Sciences Inc. (ELNSF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ELNSF?

Before investing in Element Nutritional Sciences Inc. (ELNSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ELNSF to a portfolio?

Potential reasons to consider Element Nutritional Sciences Inc. (ELNSF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Proprietary formulations like Rejuvenate.. Additionally: Direct-to-consumer sales channel.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ELNSF?

Yes, most major brokerages offer fractional shares of Element Nutritional Sciences Inc. (ELNSF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ELNSF's earnings and financial reports?

Element Nutritional Sciences Inc. (ELNSF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ELNSF earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Financial data is based on the most recent available information.
  • OTC market data may be limited and subject to inaccuracies.
  • CEO background information is incomplete.
Datenquellen

Popular Stocks